Hikari Power’s TG Therapeutics TGTX Stock Holding History

Hikari Power’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$275K	Buy	+5,000	New	+$205K	0.03%	37
2021 Q2	–	Sell	-5,000	Closed	-$241K	–	71
2021 Q1	$241K	Hold	5,000	–	–	0.03%	59
2020 Q4	$260K	Buy	+5,000	New	+$169K	0.03%	63
2020 Q3	–	Sell	-10,000	Closed	-$195K	–	62
2020 Q2	$195K	Hold	10,000	–	–	0.03%	57
2020 Q1	$98K	Buy	+10,000	New	+$126K	0.01%	78
2019 Q4	–	Sell	-50,000	Closed	-$281K	–	119
2019 Q3	$281K	Hold	50,000	–	–	0.03%	84
2019 Q2	$433K	Hold	50,000	–	–	0.05%	76
2019 Q1	$402K	Hold	50,000	–	–	0.04%	80
2018 Q4	$205K	Sell	50,000 -110,000	-69%	-$547K	0.02%	114
2018 Q3	$896K	Hold	160,000	–	–	0.09%	70
2018 Q2	$2.1M	Hold	160,000	–	–	0.23%	50
2018 Q1	$2.27M	Hold	160,000	–	–	0.27%	45
2017 Q4	$1.31M	Hold	160,000	–	–	0.15%	55
2017 Q3	$1.9M	Buy	160,000 +100,000	+167%	+$1.14M	0.25%	42
2017 Q2	$603K	Hold	60,000	–	–	0.08%	61
2017 Q1	$699K	Buy	+60,000	New	+$431K	0.1%	52

Other funds holding TGTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return

Hikari Power's TGTX Position: Q2 2026 in Review

Hikari Power opened a new position in TG Therapeutics (TGTX) in Q2 2026: 5,000 shares worth $275K. The stake represents 0.03% of the portfolio and ranks #37 among its holdings. This is a return to the name: Hikari Power previously reported a position in TGTX as recently as Q1 2021.

Hikari Power first reported a position in TGTX in Q1 2017 and has held it in 16 quarters since. The position peaked at $2.27M in Q1 2018. 236 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

Hikari Power held 5,000 shares of TG Therapeutics worth $275K as of Q2 2026.
TG Therapeutics was a new Hikari Power position in Q2 2026.
TG Therapeutics made up 0.03% of Hikari Power's portfolio in Q2 2026, its #37 holding.
Hikari Power first reported a position in TG Therapeutics in Q1 2017 and has held it in 16 quarters since.
Hikari Power's TG Therapeutics position peaked at $2.27M in Q1 2018.
236 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Hikari Power's 13F filing for Q2 2026, filed 7 Aug 2026.